https://www.biospace.com/avistone-pharmaceuticals-secures-200-million-strategic-investment-from-vivo-capital-bain-capital-and-primavera-capital
Avistone Pharmaceuticals Secures $200 Million Strategic Investment from Vivo Capital, Bain Capital...
Dec 8, 2021 - Avistone Pharmaceuticals today announced it has received a strategic investment of more than $200 million led by Vivo Capital with participation from Bain...
200 millionstrategic investmentvivo capitalpharmaceuticalssecures